Literature DB >> 31983918

Effect of bacillus bacterial extracts on the expression of major histocompatibility complex Class I and Class II receptors on MDA-MB 231 breast cancer cells.

Waleed Alabdulmonem1.   

Abstract

OBJECTIVE: The expression of human leukocyte antigen (HLA)-ABC and HLA-DR is linked to the development of breast cancer. This study was aimed to determine the effect of bacillus bacterial extracts on the expression of the major histocompatibility complexes (MHC) Class I and Class II receptors on breast cancer cells.
METHODS: The expression of HLA-ABC and HLA-DR was assessed by flow cytometry and confocal microscope on the human breast tumor cell lines MDA-MB-231, which used a readily accessible model system. It is postulated that the HLA-ABC and HLA-DR receptors might be regulated by bacillus bacterial extracts designated (RA10, RA4, RA7, and RA16).
RESULTS: It was observed that the treatment of cell line MDA-MB-231 with the RA10 resulted in an upregulation of the cell surface expression of the HLA-A, B, C receptors. It was observed that RA10 has the capacity to reduce the expression of HLA-A, B, C, it also shows a detectable degree of cytotoxicity when used at high concentrations. The data show that the cell surface expression of HLA-ABC is higher than HLA-DR. No significant changes of HLA-DR expression were observed on MDA-MB-231 cell lines.
CONCLUSIONS: Improved understanding of the connection between HLA-ABC, HLA-DR, and bacterial extracts such as RA10 may lead to the development of drug design and therapies related to breast cancer condition in which these receptors are involved. Copyright: © International Journal of Health Sciences.

Entities:  

Keywords:  Bacillus bacterial extracts; breast cancer cells; major histocompatibility complexes Class I receptor; major histocompatibility complexes Class II receptor

Year:  2020        PMID: 31983918      PMCID: PMC6968881     

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  20 in total

1.  Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. 1986.

Authors:  Klas Kärre; Hans Gustaf Ljunggren; Gerald Piontek; Rolf Kiessling
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

Review 2.  MHC II and the endocytic pathway: regulation by invariant chain.

Authors:  O J B Landsverk; O Bakke; T F Gregers
Journal:  Scand J Immunol       Date:  2009-09       Impact factor: 3.487

3.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

4.  Influence of major histocompatibility complex on bacterial composition of fecal flora.

Authors:  P Toivanen; J Vaahtovuo; E Eerola
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 5.  Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.

Authors:  F Garrido; F Ruiz-Cabello; T Cabrera; J J Pérez-Villar; M López-Botet; M Duggan-Keen; P L Stern
Journal:  Immunol Today       Date:  1997-02

6.  Epigallocatechin-3-O-gallate modulates global microRNA expression in interleukin-1β-stimulated human osteoarthritis chondrocytes: potential role of EGCG on negative co-regulation of microRNA-140-3p and ADAMTS5.

Authors:  Zafar Rasheed; Naila Rasheed; Osama Al-Shaya
Journal:  Eur J Nutr       Date:  2017-01-21       Impact factor: 5.614

7.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.

Authors:  Jason Greenbaum; John Sidney; Jolan Chung; Christian Brander; Bjoern Peters; Alessandro Sette
Journal:  Immunogenetics       Date:  2011-02-09       Impact factor: 2.846

8.  HLA Class II Antigen Presentation in Prostate Cancer Cells: A Novel Approach to Prostate Tumor Immunotherapy.

Authors:  Bently Patrick Doonan; Azizul Haque
Journal:  Open Cancer Immunol J       Date:  2010-01-01

9.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

10.  Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro.

Authors:  Meenakshi Shukla; Kalpana Gupta; Zafar Rasheed; Khursheed A Khan; Tariq M Haqqi
Journal:  J Inflamm (Lond)       Date:  2008-06-13       Impact factor: 4.981

View more
  1 in total

1.  Quantifying the efficacy of checkpoint inhibitors on CD8+ cytotoxic T cells for immunotherapeutic applications via single-cell interaction.

Authors:  Matthew Ryan Sullivan; Giovanni Stefano Ugolini; Saheli Sarkar; Wenjing Kang; Evan Carlton Smith; Seamus Mckenney; Tania Konry
Journal:  Cell Death Dis       Date:  2020-11-13       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.